Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sarawak Biodiversity Council currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to a distinct examiner and a distinct art unit, showing a concentrated prosecution profile.
CRAIGO, BAHAR ALAWI is the busiest examiner with 1 pending office action. This individual manages the company's entire current pending workload, consolidating all patent office activity within the identified art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CRAIGO, BAHAR ALAWI | 1 | 47.3% | +27.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18259761 | COMPOUND FOR TREATING NEURODEGENERATIVE DISEASES AND ITS ISOLATION METHOD THEREOF | CRAIGO, BAHAR ALAWI | 3d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18259761 | COMPOUND FOR TREATING NEURODEGENERATIVE DISEASES AND ITS ISOLATION METHOD THEREOF | CRAIGO, BAHAR ALAWI | 3d overdue |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18259761 | COMPOUND FOR TREATING NEURODEGENERATIVE DISEASES AND ITS ISOLATION METHOD THEREOF | CRAIGO, BAHAR ALAWI | 1699 | §101§102 | Non-Final OA | 3d overdue | Pending | Jun 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSarawak Biodiversity Council has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Bahar Alawi Craigo has the most, with 1 of Sarawak Biodiversity Council's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
